Human Lung Tumor into NOD-scid IL 2 R the Implantation of Non-Disrupted Pieces of Tumor-Derived Memory T Cells Following Long-Term Engraftment and Expansion of Barcos and

[1]  S. D. Hess,et al.  Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies. , 2001, Trends in immunology.

[2]  J. Bernstein,et al.  IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells. , 2006, Clinical immunology.

[3]  G. Gherardi,et al.  THE SCID MOUSE REACTION TO HUMAN PERIPHERAL BLOOD MONONUCLEAR LEUKOCYTE ENGRAFTMENT: NEUTROPHIL RECRUITMENT INDUCED EXPRESSION OF A WIDE SPECTRUM OF MURINE CYTOKINES AND MOUSE LEUKOPOIESIS, INCLUDING THYMIC DIFFERENTIATION , 1995, Transplantation.

[4]  R. Woodland,et al.  A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. , 2008, Clinical immunology.

[5]  Mamoru Ito,et al.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. , 2002, Blood.

[6]  Markus G. Manz,et al.  Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice , 2004, Science.

[7]  W. Fanslow,et al.  Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand. , 1995, Journal of immunology.

[8]  J. Shiroko,et al.  Antitumor efficacy of a human interleukin-12 expression plasmid demonstrated in a human peripheral blood leukocyte/human lung tumor xenograft SCID mouse model , 2001, Cancer Gene Therapy.

[9]  T. Lebien,et al.  Murine and Human IL-7 Activate STAT5 and Induce Proliferation of Normal Human Pro-B Cells1 , 2005, The Journal of Immunology.

[10]  S. D. Hess,et al.  SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions. , 2002, Frontiers in bioscience : a journal and virtual library.

[11]  M. Kotb,et al.  Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12 , 2004, The Journal of Immunology.

[12]  S. Bernstein,et al.  Human CD4+ T Cells Present Within the Microenvironment of Human Lung Tumors Are Mobilized by the Local and Sustained Release of IL-12 to Kill Tumors In Situ by Indirect Effects of IFN-γ1 , 2003, The Journal of Immunology.

[13]  T. Tsuruo,et al.  Novel metastasis model of human lung cancer in SCID mice depleted of NK cells , 1996, International journal of cancer.

[14]  W. Leonard,et al.  Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. , 1995, Immunity.

[15]  A. Kelleher,et al.  The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostasis and the challenges facing its utilization as a novel therapy. , 2006, Current drug targets.

[16]  A. Cumano,et al.  Molecular and functional evidence for activity of murine IL-7 on human lymphocytes. , 2006, Experimental hematology.

[17]  L. Matrisian,et al.  Tumor progression: Defining the soil round the tumor seed , 2001, Current Biology.

[18]  Dale L. Greiner,et al.  Humanized mice in translational biomedical research , 2007, Nature Reviews Immunology.

[19]  Y. Sugiyama,et al.  Human Inflammatory Cells Within the Tumor Microenvironment of Lung Tumor Xenografts Mediate Tumor Growth Suppression in Situ that Depends on and Is Augmented by Interleukin-12 , 2001, Journal of immunotherapy.

[20]  D. Longo,et al.  Human‐mouse lymphoid chimeras: host‐vs.‐graft and graft‐vs.‐host reactions , 1992, European journal of immunology.

[21]  Y. Ueyama,et al.  Functional Human T Lymphocyte Development from Cord Blood CD34+ Cells in Nonobese Diabetic/Shi-scid, IL-2 Receptor γ Null Mice1 , 2002, The Journal of Immunology.

[22]  T. Umemoto,et al.  Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies. , 1992, Journal of immunology.

[23]  R. J. Kelleher,et al.  Human CD4+ Effector Memory T Cells Persisting in the Microenvironment of Lung Cancer Xenografts Are Activated by Local Delivery of IL-12 to Proliferate, Produce IFN-γ, and Eradicate Tumor Cells1 , 2005, The Journal of Immunology.

[24]  H. Asao,et al.  Cutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex1 , 2001, The Journal of Immunology.

[25]  F. Gage,et al.  Development of functional human embryonic stem cell-derived neurons in mouse brain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Gaedeke,et al.  Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Taniguchi,et al.  A novel monoclonal antibody against murine IL-2 receptor beta-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. , 1991, Journal of immunology.

[28]  Michael Loran Dustin,et al.  Reprogramming T cells: the role of extracellular matrix in coordination of T cell activation and migration. , 2001, Current opinion in immunology.

[29]  T. Tlsty,et al.  Stromal cells can contribute oncogenic signals. , 2001, Seminars in cancer biology.

[30]  H. Takita,et al.  Antitumor immune response of human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice. , 1997, Cancer research.

[31]  T. Umemoto,et al.  Engraftment of human tumor-infiltrating lymphocytes and the production of anti-tumor antibodies in SCID mice. , 1996, Journal of immunology.

[32]  A. Bothwell,et al.  Bone marrow abnormalities in the non-obese diabetic mouse. , 1993, International immunology.

[33]  M. Tary‐Lehmann,et al.  Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood , 1992, The Journal of experimental medicine.

[34]  T. Blankenstein,et al.  Tumor Rejection by Disturbing Tumor Stroma Cell Interactions , 2001, The Journal of experimental medicine.

[35]  K. Akashi,et al.  Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. , 2005, Blood.

[36]  H. Gaskins,et al.  Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. , 1993, Journal of immunology.

[37]  F. Lozupone,et al.  Murine granulocytes control human tumor growth in SCID mice , 2000, International journal of cancer.

[38]  N. Tanaka,et al.  The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. , 1996, Annual review of immunology.

[39]  H. Takita,et al.  Human lung tumor growth established in the lung and subcutaneous tissue of mice with severe combined immunodeficiency. , 1987, Cancer research.

[40]  R. Bankert,et al.  Membrane-Associated TGF-β1 Inhibits Human Memory T Cell Signaling in Malignant and Nonmalignant Inflammatory Microenvironments1 , 2006, The Journal of Immunology.

[41]  R. J. Kelleher,et al.  Characterization of Human Lung Tumor-Associated Fibroblasts and Their Ability to Modulate the Activation of Tumor-Associated T Cells1 , 2007, The Journal of Immunology.

[42]  M. Miyasaka,et al.  Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice , 1993, The Journal of experimental medicine.